{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:28:51Z","timestamp":1772810931227,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:00:00Z","timestamp":1716076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ejso.2024.108429","type":"journal-article","created":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T21:57:11Z","timestamp":1716155831000},"page":"108429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness and safety of computed tomography-guided high-dose-rate brachytherapy in treating recurrent hepatocellular carcinoma not amenable to repeated resection or radiofrequency ablation"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5763-689X","authenticated-orcid":false,"given":"Timo Alexander","family":"Auer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melina","family":"Anhamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8819-6209","authenticated-orcid":false,"given":"Georg","family":"B\u00f6ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-3268","authenticated-orcid":false,"given":"Uli","family":"Fehrenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzel","family":"Sch\u00f6ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Lurje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9948-7220","authenticated-orcid":false,"given":"Bernhard","family":"Gebauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Collettini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2024.108429_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN Estimates of Incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.ejso.2024.108429_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108429_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ejso.2024.108429_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Electronic address eee, European Association for the study of the L. EASL clinical Practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.ejso.2024.108429_bib5","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.1007\/s00330-020-06990-8","article-title":"Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (\u2264 5 cm) after initial curative resection","volume":"30","author":"Feng","year":"2020","journal-title":"Eur Radiol"},{"issue":"13","key":"10.1016\/j.ejso.2024.108429_bib6","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.4254\/wjh.v7.i13.1755","article-title":"Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma","volume":"7","author":"Lacaze","year":"2015","journal-title":"World J Hepatol"},{"issue":"7","key":"10.1016\/j.ejso.2024.108429_bib7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00270-020-02471-z","article-title":"CIRSE standards of Practice on thermal ablation of liver tumours","volume":"43","author":"Crocetti","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108429_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijrobp.2009.07.1700","article-title":"Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival","volume":"78","author":"Mohnike","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ejso.2024.108429_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00066-016-0957-0","article-title":"Radioablation of liver malignancies with interstitial high-dose-rate brachytherapy : complications and risk factors","volume":"192","author":"Mohnike","year":"2016","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"10.1016\/j.ejso.2024.108429_bib10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00330-011-2352-7","article-title":"Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours","volume":"22","author":"Collettini","year":"2012","journal-title":"Eur Radiol"},{"issue":"10","key":"10.1016\/j.ejso.2024.108429_bib11","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1016\/j.ejrad.2013.04.046","article-title":"Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum","volume":"82","author":"Collettini","year":"2013","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108429_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.annonc.2021.02.014","article-title":"Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines","volume":"32","author":"Vogel","year":"2021","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108429_bib13","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232044","article-title":"CT-Guided high-dose-rate brachytherapy versus transarterial chemoembolization in patients with unresectable hepatocellular carcinoma","volume":"310","author":"Auer","year":"2024","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ejso.2024.108429_bib14","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.ijrobp.2003.09.024","article-title":"CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique","volume":"58","author":"Ricke","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejso.2024.108429_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"10","key":"10.1016\/j.ejso.2024.108429_bib16","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jvir.2017.06.019","article-title":"Proposal of a new Adverse event Classification by the Society of interventional Radiology standards of Practice committee","volume":"28","author":"Khalilzadeh","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108429_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.14701\/ahbps.2020.24.4.431","article-title":"Prognosis after intrahepatic recurrence in the patients who underwent curative resection for hepatocellular carcinoma","volume":"24","author":"Lee","year":"2020","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.ejso.2024.108429_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.574668","article-title":"Diffuse recurrence of hepatocellular carcinoma after liver resection: transarterial chemoembolization (TACE) Combined with sorafenib versus TACE Monotherapy","volume":"10","author":"Yao","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108429_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11901-020-00559-1","article-title":"Stereotactic body radiation therapy (SBRT) in hepatocellular carcinoma","volume":"20","author":"Thomas","year":"2021","journal-title":"Current Hepatology Reports"},{"issue":"1","key":"10.1016\/j.ejso.2024.108429_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jhep.2020.03.005","article-title":"Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma","volume":"73","author":"Kim","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.ejso.2024.108429_bib21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ijrobp.2017.01.221","article-title":"Predictors of liver Toxicity following stereotactic body radiation therapy for hepatocellular carcinoma","volume":"97","author":"Velec","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejso.2024.108429_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13014-021-01779-5","article-title":"Radiotherapeutic treatment options for oligotopic malignant liver lesions","volume":"16","author":"Wust","year":"2021","journal-title":"Radiat Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324004815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324004815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T23:55:28Z","timestamp":1719705328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324004815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0748798324004815"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108429","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of computed tomography-guided high-dose-rate brachytherapy in treating recurrent hepatocellular carcinoma not amenable to repeated resection or radiofrequency ablation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108429"}}